Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07477860
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 25 years
* Subject provides written informed consent
* Patient with Achilles tendinopathy refractory to 3 months of conservative management
* Self reported pain of at least 4/10 on visual analog scale (VAS)
* Non-surgical candidate/looking to avoid surgery
Exclusion Criteria:
* Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle/ligament injury, tendon rupture, and etiologies related to bone mineral density
* Steroid injection in the last 90 days from the embolization procedure
* Known severe allergy to Lipiodol and/or iodinated contrast media
* Diagnosis of peripheral arterial disease affecting the lower extremities
* Pregnancy or breastfeeding
* Anticoagulation or irreversible coagulopathy
* GFR \<45 or Serum creatinine \> 2.0 mg/dl
* Type 1 Diabetes Mellitus
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
25 Years
Maximum Age:
80 Years
Study:
NCT07477860
Study Brief:
Protocol Section:
NCT07477860